ライフサイエンスコーパス: prognostic factor

1 t retransplantation was the only significant prognostic factor.

2 es and neutrophils represents an independent prognostic factor.

3 any site is common but is not an independent prognostic factor.

4 Ki-67 index was proposed to be an additional prognostic factor.

5 of MBC patients and may represent a negative prognostic factor.

6 ivation of the COX-2 pathway, was a negative prognostic factor.

7 tional hazards models adjusting for baseline prognostic factors.

8 o consensus on which biomarkers are reliable prognostic factors.

9 ter adjusting for socioeconomic, clinic, and prognostic factors.

10 rgical unit were not found to be significant prognostic factors.

11 onsider prioritizing individuals with poorer prognostic factors.

12 dy to characterise its clinical features and prognostic factors.

13 s was used to match patients for seven known prognostic factors.

14 ostic information to the clinicopathological prognostic factors.

15 Ki-67 labelling index (LI) were detected as prognostic factors.

16 th mortality, while controlling for known MM prognostic factors.

17 s were employed to determine the independent prognostic factors.

18 CI: 0.42-0.78, P < 0.0001) were independent prognostic factors.

19 fects may counteract the effects of negative prognostic factors.

20 ort, and extended to include other important prognostic factors.

21 l (P < 0.0001), independently of established prognostic factors.

22 ast 30 years while taking into account other prognostic factors.

23 outcomes based on genetic, histological, and prognostic factors.

24 , and DFSP tumor size appear to be important prognostic factors.

25 n in addition to conventional tumor acquired prognostic factors.

26 and CTC number were significant independent prognostic factors.

27 group B) were additional independent adverse prognostic factors.

28 l PET features in the context of established prognostic factors.

29 nt extrahepatic disease (EHD), and to define prognostic factors.

30 an excellent outcome regardless of baseline prognostic factors.

31 oblastic leukaemia characterised by negative prognostic factors.

32 nt extrahepatic disease (EHD), and to define prognostic factors.

33 invasion and lymph node metastasis are poor prognostic factors.

34 which were of advanced age and with adverse prognostic factors.

35 lcohol relapse (P < 0.0001) were independent prognostic factors.

36 was observed after controlling for multiple prognostic factors.

37 by age, response to second-line therapy, and prognostic factors.

38 Disease (P < 0.0001) scores were independent prognostic factors.

39 re lower for BCS but not after adjusting for prognostic factors.

40 of patients in the nivolumab group with poor prognostic factors.

41 res of PDACs with dMMR or MSI might serve as prognostic factors.

42 es accounting for standard clinicopathologic prognostic factors (10-year biochemical recurrence-free

43 Established IHD was an important prognostic factor across all HF types.

44 c survival models were built including known prognostic factors (age, diagnostic delay and site of on

45 The following potential prognostic factors-age, trial, number of prior chemother

46 dation improved the model using conventional prognostic factors alone (P = .007).

47 pared with those generated with conventional prognostic factors alone in terms of log-rank statistic

48 factors to those generated with conventional prognostic factors alone.

49 ted the strength of association between each prognostic factor and long-term mortality.

50 t lymph node capsular status is an important prognostic factor and should be considered for the futur

51 c regression models, adjusting for important prognostic factors and clustering effects.

52 rmed a multi-institutional study to identify prognostic factors and determine outcomes for patients w

53 s association was found between the main CRC prognostic factors and high values of NLR, PLR and PC.

54 s, multistate models allow for dissection of prognostic factors and intermediate events in the analys

55 ficant prognostic value to existing clinical prognostic factors and may facilitate more individualize

56 The prognostic factors and optimal therapy for invasive pulm

57 els that simultaneously consider a number of prognostic factors and provide an estimate of patients'

58 assifier was stronger than existing clinical prognostic factors and remained a strong independent pro

59 Preoperative prognostic factors and risk stratification for postopera

60 d meta-analysis of studies that investigated prognostic factors and survival in patients with progres

61 , PLR and PC correlate with other well-known prognostic factors and survival of patients with colorec

62 ct of these SNPs is independent of classical prognostic factors and there is no heterogeneity between

63 Objective: To assess prognostic factors and to evaluate the influence of trea

64 rognostic value of EDI was superior to known prognostic factors and was enhanced with the addition of

65 To investigate the phenotypic spectrum, prognostic factors, and genotype-specific differences, w

66 outcome measures were tumor characteristics, prognostic factors, and overall survival in months.

67 -to-severe comorbidity adjusting for age, PC prognostic factors, and treatment.

68 Prognostic factors are awaited to optimize the clinical

69 Several prognostic factors are known, including site of onset (b

70 Prognostic factors are lacking in neurosarcoidosis (NS),

71 Long-term survival data are lacking, and prognostic factors are not well defined.

72 Long-term survival data are lacking, and prognostic factors are not well defined.

73 onal studies almost always have bias because prognostic factors are unequally distributed between pat

74 PRT was an independent prognostic factor associated with improved survival in s

75 rare but aggressive endocrine tumor, and the prognostic factors associated with long-term outcomes af

76 cohol on long-term survival and (2) identify prognostic factors at admission capable of predicting ab

77 To explore prognostic factors at baseline, patients who underwent H

78 these patients, particularly those with poor prognostic factors at diagnosis (including the presence

79 effects while integrating the most relevant prognostic factors available in clinical routine.

80 andomization balances both known and unknown prognostic factors between trial arms, thus allowing an

81 is an emerging consensus with regard to many prognostic factors, but there is a clear need to synthes

82 hic atrophy (GA) progression and to identify prognostic factors by measuring the enlargement of the a

83 ted with the bone scan index (BSI) and other prognostic factors by using the Pearson correlation coef

84 Better understanding of prognostic factors can possibly improve graft survival i

85 t low expression of miR-579-3p is a negative prognostic factor correlating with poor survival.

86 antitative imaging features and conventional prognostic factors demonstrated improved risk stratifica

87 prognostic factor effects, re-estimating all prognostic factor effects, and applying shrinkage of the

88 of the prognostic factors; re-estimating all prognostic factor effects, re-estimating all prognostic

89 ional hazards regression adjusting for known prognostic factors estimated the association of these ge

90 Propensity methods can deal with multiple prognostic factors, even if there are relatively few pat

91 ught to determine 30-day survival trends and prognostic factors following surgery for acute subdural

92 response (pCR) remains an important positive prognostic factor for an individual patient, a recent me

93 as a first symptom of occult cancer and as a prognostic factor for cancer survival is unknown.

94 t low bone mineral density is an independent prognostic factor for curve progression.

95 al residual disease was the only independent prognostic factor for death in multivariate analysis (ha

96 r 4A1 (NR4A1) in breast cancer patients is a prognostic factor for decreased survival and increased m

97 led that hypofractionation was a significant prognostic factor for FFBF and PCaSS, when adjusted for

98 value) of the MPD diameter on CT or MRI as a prognostic factor for malignant disease and to propose a

99 mm was identified as an optimal cutoff for a prognostic factor for malignant disease in MD or mixed I

100 of 7.2 mm or greater was also an independent prognostic factor for malignant neoplasms (odds ratio, 1

101 highly variable and serves as an independent prognostic factor for MCL outcome.

102 Age at diagnosis was an independent prognostic factor for metastatic breast cancer patients.

103 GEP class was the strongest prognostic factor for metastatic death in this series.

104 MRD, identified as a new prognostic factor for ML-DS patients, can be used for ri

105 e analysis, the LNR was the only independent prognostic factor for OS but was influenced by the total

106 LNR exceeding 0.20 was the only independent prognostic factor for OS in N1 patients after liver rese

107 r sequentially or concurrently, was a strong prognostic factor for OS.

108 nical benefit on Mainsail was an independent prognostic factor for OS.

109 revealed that reduced MPV was an independent prognostic factor for overall survival (hazard ratio, 1.

110 evealed that elevated PDW was an independent prognostic factor for overall survival (hazard ratio, 2.

111 deriving clinical benefit was an independent prognostic factor for overall survival (OS) in a post ho

112 Response to rituximab induction remained a prognostic factor for overall survival despite treatment

113 f IL-6R mRNA in tumor tissues was a positive prognostic factor for overall survival.

114 etectable viral DNA titre was an independent prognostic factor for overall survival.

115 REST activity, REST score was found to be a prognostic factor for overall survival.

116 ntified response to rituximab induction as a prognostic factor for overall survival.

117 MTV) on (18)F-FDG PET was found to be a poor prognostic factor for patients treated with chemoradioth

118 ls in the surgical specimen, is an important prognostic factor for patients with pancreatic ductal ad

119 lary disease at diagnosis was an independent prognostic factor for PFS and OS, whereas PET-CT normali

120 zation before maintenance was an independent prognostic factor for PFS.

121 djacent normal tissues and is an independent prognostic factor for poor overall and disease free surv

122 dissection group, were a strong, independent prognostic factor for recurrence (hazard ratio, 1.78; P=

123 easing age or BMI at baseline was a negative prognostic factor for remission.

124 IC, but not TC, was an independent favorable prognostic factor for RFS and OS adjusted for age, gende

125 plex karyotype aberrations as an independent prognostic factor for survival after front-line therapy.

126 lation of PTEN to be an independent negative prognostic factor for survival in both the KMC (hazard r

127 d with amyloid burden and was an independent prognostic factor for survival in this cohort of patient

128 arital status was found to be an independent prognostic factor for survival in various cancer types.

129 Baseline QOL was an independent prognostic factor for survival.

130 currence of autoimmune disease is a negative prognostic factor for survival.

131 Tumor size is a prognostic factor for the majority of solid cancers, but

132 Overall tumor burden may be an important prognostic factor for these patients.

133 MRD status was an independent prognostic factor for time to progression (TTP) (hazard

134 ibed that DDIT4 expression is an independent prognostic factor for tripe negative breast cancer resis

135 resent study evaluated safety, efficacy, and prognostic factors for (90)Y-yttrium microsphere radioem

136 To assess prognostic factors for a second clinical attack and a fi

137 level greater than 10 mg/dL are independent prognostic factors for adverse outcomes in AC.

138 udy of ambulatory DCM patients, we show that prognostic factors for all-cause DCM also predict outcom

139 carcinoma (ICC) in Thailand and identify the prognostic factors for all-causes of death.

140 s (8.1% of patients) represented significant prognostic factors for an unfavorable survival, independ

141 cohorts to identify clinical diagnostic and prognostic factors for anthrax meningitis.

142 n and microvascular tumor invasion were poor prognostic factors for both OS and DFS, presence of sate

143 l thickness and obstruction were significant prognostic factors for cardiovascular death.

144 o CCC pathogenesis and the identification of prognostic factors for CCC progression.

145 mic assays such as RS with clinicopathologic prognostic factors for chemotherapy indication in early

146 Assessment of disease extent and of prognostic factors for complications is paramount to gui

147 In a prospective trial that investigated prognostic factors for development of NEC in high-risk n

148 receptor, tumor size, and RS were univariate prognostic factors for disease-free survival; only nodal

149 bMTV and refractory disease were independent prognostic factors for EFS.

150 Other prognostic factors for increased tuberculosis-related mo

151 oth GEP and LBD of the tumor are independent prognostic factors for metastasis and metastatic death i

152 study of GEP testing and other conventional prognostic factors for metastasis and metastatic death i

153 phagocytic lymphohistiocytosis, and the main prognostic factors for mortality.

154 perative portal blood inflow may be negative prognostic factors for MRB outcome in children with idio

155 al growth factor receptor 1 levels were poor prognostic factors for OS.

156 tatus and response are important independent prognostic factors for outcome in patients with AML achi

157 opoietic stem cell transplant as independent prognostic factors for outcome in T-LL.

158 tage, and PDW were identified as independent prognostic factors for overall survival (for PDW, P < 0.

159 ortional hazard models to assess independent prognostic factors for overall survival.

160 Identification of prognostic factors for patients with relapsed/refractory

161 ing period of 30 or more years were positive prognostic factors for PDAC.

162 FAS and p53 were shown to be prognostic factors for PFS (7.0 months if FAS+ and p53-;

163 according to treatment strategy and explored prognostic factors for PFS and OS.

164 ary keratoplasty (P = .049) were independent prognostic factors for poor graft survival.

165 (+) T cells and Foxp3(+) Tregs are favorable prognostic factors for resected HNSCC.

166 Modification in these prognostic factors for ROP did not cause an increase in

167 gnancies are associated with high mortality, prognostic factors for second malignancy influence long-

168 ined by the 2010 ACR/EULAR criteria, and had prognostic factors for severe disease progression, inclu

169 studies to assess pooled survival rates and prognostic factors for survival in patients with HCM.

170 and KIT mutation (exon 11) were significant prognostic factors for the probability of surviving beyo

171 ion of CD147 and MMP-2 expression with major prognostic factors for uveal melanoma and the developmen

172 somatic aberration and its association with prognostic factors have neither been studied in a West A

173 nce interval 9.4-46.8, P < 0.001) and a poor prognostic factor (hazard ratio 1.6, 95% confidence inte

174 d histomorphometric score was an independent prognostic factor (hazard ratio = 20.81, 95% CI: 6.42-67

175 ation remained after adjustment for clinical prognostic factors (hazard ratio [HR], 0.72; 95% CI, 0.5

176 Radiation dose was the single most important prognostic factor; higher doses correlated with an impro

177 The Ki-67 index is a strong independent prognostic factor; however, the biologic MIPI (MIPI-b) d

178 uvant treatment was an independent favorable prognostic factor (HR 0.76, 95% CI 0.58-0.99, P = 0.044)

179 For frequently examined prognostic factors, HRs derived by univariate and multiv

180 presence of excessive blasts and other poor prognostic factors, hypomethylating agents are the prefe

181 , adjusting for stratification variables and prognostic factors identified a priori, to compare rates

182 significance of combinations of significant prognostic factors identified by univariate analysis was

183 The prognostic factors identified could allow the therapy to

184 The prognostic factors identified in this study have not bee

185 medullary disease is associated with adverse prognostic factors (ie, high lactate dehydrogenase level

186 at expansion has been reported as a negative prognostic factor in amyotrophic lateral sclerosis (ALS)

187 at expansion has been reported as a negative prognostic factor in amyotrophic lateral sclerosis (ALS)

188 se to induction chemotherapy is an important prognostic factor in B-lymphoblastic leukemia (B-ALL).

189 filtrating lymphocytes (TILs) is a favorable prognostic factor in breast cancer, and TILs may synergi

190 nfiltrating lymphocytes (TIL) is a favorable prognostic factor in breast cancer, but what drives immu

191 he single most informative stage independent prognostic factor in CLL.

192 analysis showed that MPV was an independent prognostic factor in CRC (HR = 1.452, 95% CI = 1.118-1.8

193 ESRP1 loss is an adverse prognostic factor in CRC.

194 ventricular (RV) dysfunction (RVD) is a poor prognostic factor in heart failure with preserved ejecti

195 raventricular hemorrhage (IVH) is a negative prognostic factor in intracerebral hemorrhage (ICH) and

196 66.4%) and this proofed to be an independent prognostic factor in multivariate Cox analysis (hazards

197 tential oncogene and an independent negative prognostic factor in neuroblastoma.

198 methylation of WIF1 could be an independent prognostic factor in OS and PFS.

199 Lymph node (LN) involvement is a major prognostic factor in pancreatic adenocarcinoma.

200 Finally, we suggest miR-142-3p as a negative prognostic factor in patients with relapsing-remitting m

201 he CTC number before CCRT was an independent prognostic factor in patients with unresectable oesophag

202 umor was the major inferior disease-specific prognostic factor in physical scores ( P < .01), whereas

203 evels of prostate-specific antigen, the main prognostic factor in prostate cancer.

204 thologic ADC represents a strong independent prognostic factor in the evaluation of the aggressivenes

205 The MELD score can be used as a prognostic factor in this patient population and should

206 has recently been indicated as an important prognostic factor in various cancer types, but its role

207 bjectives: To validate previously identified prognostic factors in AC, evaluate the effect of timing

208 es and early treatment response are the main prognostic factors in acute myeloid leukemia (AML).

209 iFISH results are important independent prognostic factors in AL amyloidosis.

210 or bone metastasis were independent adverse prognostic factors in both groups; primary mediastinal n

211 , MRD monitoring is one of the most relevant prognostic factors in elderly MM patients, irrespectivel

212 reservoir strain) are powerful clinical and prognostic factors in HFpEF.

213 rior to using cytology and growth pattern as prognostic factors in MCL.

214 fusion-weighted (DW) imaging and established prognostic factors in metastatic castration-resistant pr

215 erapy of TACE and sorafenib were significant prognostic factors in metastatic HCC.

216 h poor outcome independently of well-defined prognostic factors in neuroblastoma, breast cancer, DLBC

217 toms, and initial BCVA appear to be reliable prognostic factors in patients undergoing combined catar

218 stases (BMM) were independently described as prognostic factors in patients with colon cancer.

219 Most data on mortality and prognostic factors in patients with heart failure come f

220 all survival when adjusting for conventional prognostic factors in patients with stage III NSCLC.

221 Cox regression was used to select and weight prognostic factors in proportion to their hazard ratios.

222 (LAVI) have been recently proposed as novel prognostic factors in several cardiovascular diseases.

223 Poor prognostic factors in the final model included segmental

224 ion also proved to be significant individual prognostic factors in this study.

225 fluence DDFI or OS after adjusting for known prognostic factors in young breast cancer patients.

226 Significant prognostic factors included the original 4 factors used

227 type and line of treatment, as well as known prognostic factors including adverse cytogenetics.

228 ry tumours and it was highly associated with prognostic factors including high Gleason score, clinica

229 cant correlation between tDV and established prognostic factors, including hemoglobin level (r = -0.5

230 the C9581 subsample in the presence of other prognostic factors, including MMR deficiency.

231 on margin after esophagectomy was (i) a poor prognostic factor independent of patient and tumor chara

232 Intrinsic subtype was the strongest prognostic factor independently associated with progress

233 studies; however, the lack of commonality of prognostic factors investigated is a significant limitat

234 hould be made on the basis of recognized AML prognostic factors, irrespective of the presence of EMD.

235 data do not provide evidence that 1 of the 2 prognostic factors is superior.

236 tional hazards modeling, class 2 GEP was the prognostic factor most strongly associated with metastas

237 liver metastases (yes vs no), and number of prognostic factors (none vs one, two, or three).

238 Also, tumor angiogenesis is an important prognostic factor of clear cell renal cell carcinoma (cc

239 ma datasets and p63-HA pathway is a negative prognostic factor of HNSCC patient survival.

240 To identify prognostic factors of and analyze the association of imm

241 ose To evaluate the incidence, outcomes, and prognostic factors of early liver failure (ELF) after tr

242 To identify prognostic factors of good neurologic outcome in patient

243 o determine the cumulative incidence and the prognostic factors of ileorectal anastomosis (IRA) failu

244 Prognostic factors of ipsilateral breast tumor recurrenc

245 This study suggests a series of prognostic factors of long-term visual outcome in BRC.

246 portional hazards model based on significant prognostic factors of overall survival was used to const

247 nd 11q deletion are two inversely correlated prognostic factors of poor outcome in neuroblastoma.

248 ltrated lymphocytes appear to be independent prognostic factors of short progression-free survival.

249 We performed a retrospective study to assess prognostic factors of survival in all allogeneic SCT rec

250 Prognostic factors of visual outcome and recurrence of C

251 eplace the balance of both known and unknown prognostic factors offered by randomization.

252 ts the MTSS1/p63 co-expression is a negative prognostic factor on patient survival, suggesting that t

253 Among clinical prognostic factors, only performance status, KIT mutatio

254 the intervention but not associated with any prognostic factor or with the outcome (other than throug

255 stigators may not have measured all relevant prognostic factors (or not accurately), and unknown fact

256 cancer, most of whom were elderly, had poor prognostic factors, or had serious comorbidities.

257 y tumor location is emerging as an important prognostic factor owing to distinct biological features.

258 y tumor location is emerging as an important prognostic factor owing to distinct biological features.

259 variable analysis after accounting for other prognostic factors (P < 0.01).

260 rank = .018) were identified as independent prognostic factors predicting a worse EFS.

261 backbone groups on the basis of established prognostic factors: PRETEXT I/II, PRETEXT III, PRETEXT I

262 ating the intercept and joint effects of the prognostic factors; re-estimating all prognostic factor

263 lysis, t(11;14) was confirmed as a favorable prognostic factor regarding hemEFS along with lower valu

264 , both SNTI and BMM are independent negative prognostic factors regarding DFS and OS, and the occurre

265 This study reanalyses pathological prognostic factors related to IBTR using long-term follo

266 evolution of the disease, knowledge of such prognostic factors should help tailor the treatment and

267 Prognostic factors significant by multivariable analysis

268 Responses occurred across all PD-L1 and poor prognostic factor subgroups.

269 nt series but was not independent from other prognostic factors such as age and age-adjusted HbF leve

270 n multivariable analysis, adjusted for known prognostic factors such as cytogenetic risk and WBC coun

271 PET/CT results and SUVs were compared with prognostic factors such as histologic grade (G1, G2, or

272 Conditioning on a prognostic factor that is independent of the exposure-an

273 iomedical literature and synthesize data for prognostic factors that predict long-term mortality in p

274 liver resection for HC and to clarify which prognostic factor (the number of positive LNs or the LN

275 After adjustment for key prognostic factors, the hazard ratio of death within 10

276 In the absence of poor prognostic factors, the management of myelodysplastic CM

277 asingly are used in addition to conventional prognostic factors to guide adjuvant chemotherapy (CT) d

278 antitative imaging features and conventional prognostic factors to those generated with conventional

279 osis, differential diagnosis, complications, prognostic factors, treatment, and prevention of second

280 We assessed mortality prognostic factors using random-effects logistic regress

281 ion of CD147 and MMP-2 expression with known prognostic factors, vasculogenic mimicry (VM), the matur

282 The most significant prognostic factor was GEP classification (exp[b], 10.33;

283 Prognostic factors were analyzed in 147 patients include

284 tratified by trial and adjusted for baseline prognostic factors were analyzed.

285 Results on most prognostic factors were consistent across methodological

286 Novel prognostic factors were delineated, and the assessment o

287 INTERPRETATION: Novel prognostic factors were delineated, and the assessment o

288 n-free survival were determined and clinical prognostic factors were identified by Cox proportional h

289 Subpopulations and prognostic factors were identified.

290 Prognostic factors were investigated using Cox proportio

291 Univariate and multivariate analyses of prognostic factors were performed.

292 Univariate and multivariate analyses of prognostic factors were performed.

293 The main prognostic factors were preoperative diagnosis, graft en

294 signed drug and dosing regimen, and baseline prognostic factors were requested from the leaders of th

295 Individual prognostic factors were then designated as strong, moder

296 between December 2015 and May 2016, and all prognostic factors were weighted for significance by haz

297 Greater weight loss was a positive prognostic factor, whereas increasing age or BMI at base

298 ined a statistically significant independent prognostic factor with a HR of 1.120 (1.050-1.180, p=0.0

299 level <50 mg/L appeared to be an independent prognostic factor with respect to overall survival (haza

300 Tumor size was a prognostic factor without significant influence on PFS a